Clinical insights from our specialists, AARO news, conference presentations, and patient education content — all written for the people who actually need to read it.
Once articles are published, this filter row will render dynamically from CMS categories.
Long-term randomised trial data shows that, for low- and intermediate-risk prostate cancer, SBRT achieves the same cancer control as surgery with significantly fewer side effects.
Read moreA practical checklist — pathology reports, imaging files, medication list — and what to expect from the 45–60 minute appointment itself.
Read moreDr Tan was elected in June 2024 to the Board of the International Stereotactic Radiosurgery Society — the world's largest radiosurgery professional body.
Read moreSpaceOAR hydrogel reduces rectal-side effects in prostate SBRT. Here's how we decide whether to recommend it.
Read moreWhat's claimable, what isn't, and how to navigate pre-authorisation with major Integrated Shield Plans.
Read moreOur team presented research on oligometastatic SBRT outcomes, prostate adaptive replanning, and brain SRS sequencing.
Read moreWe send a short monthly newsletter with our latest clinical insights and AARO news. No spam.